Biotechnews shows biotech is flourishing in Nijmegen

17 / 12 / 2020

Several Nijmegen based biotech-companies share their story in the latest edition of Biotechnews!

Biotechnews shows biotech is flourishing in Nijmegen

In the media

Several Nijmegen based biotech-companies share their story in the latest edition of Biotechnews!

Check out the magazine and learn more about the exciting biotech-innovations that Nijmegen entrepreneurs and researchers are working on.

 

OVERVIEW

SPL Medical started with registration trial ‘Ferrotran’. CBO Harrie van Baars on the possibilities of their mean, which offers a very rapid diagnosis of extremely small tumors in the lymph nodes. Read more!

 

Protinhi Therapeutics on the efficacy of broad-spectrum virus inhibitors. Recently they started two innovative projects on the development of antiviral medicine. Read more! 

 

HCM Medical receives GMP certificate. With this certificate, they are allowed to produce medicine for clinical research, an important milestone for the Nijmegen biotech-company. Read more!

 

Saillant Therapeutics develops generic virus inhibiting therapy. Read more!

 

Kadans Science Partner on the added value of a campus environment to the success of life sciences companies. Read more!

 

Mercachem Syncom changes name to Symeres. The new name reflects the evolution of the company: their integrated drugs discovery and development services are growing, complementing the company’s strong reputation in synthetic discovery and development chemistry. Read more!

 

Khondrion receives rare pediatric disease designation for Sonlicromanol from US FDA. Read more!

 

HAN BioCentre 15 year anniversary. Time to look back and forward. Read more!